Assignee
THORNHILL THERAPEUTICS INC
US·0 granted patents·9 pending applications·0 citations·filing 2023–2025
Top patents by PatentIndex Score
9 records- 0189US2025255938A1Cholix toxin-derived fusion molecules for oral delivery of biologically active cargoTHORNHILL THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0285US2024207372A1Cholix toxin-derived fusion molecules for oral delivery of biologically active cargoTHORNHILL THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0382US2025108118A1Cholix-derived carriers for oral delivery of heterologous payloadTHORNHILL THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0478US2024238429A1Delivery constructs for transcytosis and related methodsTHORNHILL THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0576US2026001927A1Compositions, formulations and interleukin production and purificationTHORNHILL THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0673US2025242039A1Toxin-derived delivery constructsTHORNHILL THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0771US2024299565A1Toxin-derived delivery constructsTHORNHILL THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0869US2025099599A1Furin-cleavable delivery constructsTHORNHILL THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0959US2025235506A1Chimeric il-10/carrier constructs for treatment of pouchitis and methods of useTHORNHILL THERAPEUTICS INC·Filed 2024·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →